21 March 2024

GSK Stockmann contributed to the publication of the Chambers Global Practice Guide – Shareholders’ Rights & Shareholder Activism

The new edition of the Global Practice Guide – Shareholders’ Rights & Shareholder Activism has been published by Chambers.

The guide features 18 jurisdictions and provides the latest legal information on voting requirements and the proposal of resolutions, shareholders’ rights to appoint/remove/challenge directors and in the event of liquidation/insolvency, shareholder activist strategies, and remedies available to shareholders against the company and directors.

The guide contains two sections: The “Law & Practice” section provides easily accessible information on navigating the legal system when conducting business in the jurisdiction. Leading lawyers explain local law and practice at key transactional stages and for crucial aspects of doing business. The “Trends & Developments” section gives an overview of current trends and developments in local legal markets. Leading lawyers analyse particular trends or provide a broader discussion of key developments in the jurisdiction.

GSK Stockmann contributed to the guide’s publication: Dr. Philipp Mössner (Partner at GSK Stockmann in Luxembourg), Anna Lindner (Local Partner at GSK Stockmann in Luxembourg), Chara Papagiannidi (Senior Associate at GSK Stockmann in Luxembourg) and Maria Gusinski (Associate at GSK Stockmann in Luxembourg) composed the section “Shareholders’ Rights & Shareholder Activism – Luxembourg Law & Practice”.

This chapter was originally published in the Chambers Global Practice Guide – Securitisation and is available for download as a PDF file; the whole guide is free to access as eGuide and on the Chambers website.

Print


Press contact
Beate Dünschede
+352 271802-29
beate.duenschede@gsk-lux.com

Back

GSK Updates
  • 28.02.2024

    GSK Update: GSK Stockmann contributed to the publication of the International Comparative Legal Guide to Mergers and Acquisitions

    Read more
  • 12.02.2024

    GSK Update: ESG regulation – an outlook on developments for the year 2024

    Read more
  • 12.02.2024

    GSK Update: Green securitisations under the new Europe-an Green Bonds Regulation

    Read more
Contact person

Dr. Philipp Mössner, LL.M. (McGill)

Partner

+352 271802-40

philipp.moessner@gsk-lux.com

Anna Lindner

Local Partner

+352 271802-43

anna.lindner@gsk-lux.com

Chara Papagiannidi, LL.M.

Senior Associate

+352 271802-91

chara.papagiannidi@gsk-lux.com

Maria Gusinski

Associate

+352 271802-440

maria.gusinski@gsk-lux.com

© GSK Stockmann 2024